#BEGIN_DRUGCARD DB04075

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
1188-37-0

# ChEBI_ID:
17533

# Chemical_Formula:
C7H11NO5

# Chemical_IUPAC_Name:
(2S)-2-acetamidopentanedioic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-Acetyl-L-Glutamate

# HET_ID:
NLG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H11NO5/c1-4(9)8-5(7(12)13)2-3-6(10)11/h5H,2-3H2,1H3,(H,8,9)(H,10,11)(H,12,13)/t5-/m0/s1

# InChI_Key:
InChIKey=RFMMMVDNIPUKGG-YFKPBYRVSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00624

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4075

# Mechanism_Of_Action:
Not Available

# Melting_Point:
199 Â°C

# Molecular_Weight_Avg:
189.1659

# Molecular_Weight_Mono:
189.063722467

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GS5

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.67

# Predicted_LogS:
-1

# Predicted_Water_Solubility:
1.86e+01 g/l

# Primary_Accession_No:
DB04075

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
70914

# PubChem_Substance_ID:
46507366

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02356

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(=O)N[C@@H](CCC(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:55 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M21446

# Drug_Target_1_GenBank_ID_Protein:
145334

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
argB

# Drug_Target_1_Gene_Sequence:
>777 bp
ATGATGAATCCATTAATTATCAAACTGGGCGGCGTACTGCTGGATAGTGAAGAGGCGCTG
GAACGTCTGTTTAGCGCACTGGTGAATTATCGTGAGTCACATCAGCGTCCGCTGGTGATT
GTGCACGGCGGCGGTTGCGTGGTGGATGAGCTGATGAAAGGGCTGAATCTGCCGGTGAAA
AAGAAAAACGGCCTGCGGGTGACGCCTGCTGATCAGATAGACATTATCACCGGAGCACTG
GCGGGAACGGCAAATAAAACCCTGTTGGCATGGGCGAAGAAACATCAGATTGCGGCCGTA
GGTTTGTTTCTCGGTGACGGCGACAGCGTCAAAGTGACCCAGCTTGATGAAGAGTTAGGT
CATGTTGGACTGGCGCAGCCAGGTTCGCCTAAGCTTATCAACTCCTTGCTGGAGAACGGT
TATCTGCCGGTGGTCAGCTCCATTGGCGTAACAGACGAAGGGCAACTGATGAACGTCAAT
GCCGACCAGGCGGCAACGGCGCTGGCGGCAACGCTGGGCGCGGATCTGATTTTGCTCTCC
GACGTCAGCGGCATTCTCGACGGCAAAGGGCAACGCATTGCCGAAATGACCGCCGCGAAA
GCAGAACAACTGATTGAGCAGGGCATTATTACTGACGGCATGATAGTGAAAGTGAACGCG
GCGCTGGATGCGGCCCGCACGCTGGGCCGTCCGGTAGATATCGCCTCCTGGCGTCATGCG
GAGCAGCTTCCGGCACTGTTTAACGGTATGCCGATGGGTACGCGGATTTTAGCTTAA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
10393305	Gil F, Ramon-Maiques S, Marina A, Fita I, Rubio V: N-Acetyl-L-glutamate kinase from Escherichia coli: cloning of the gene, purification and crystallization of the recombinant enzyme and preliminary X-ray analysis of the free and ligand-bound forms. Acta Crystallogr D Biol Crystallogr. 1999 Jul;55(Pt 7):1350-2.
12005432	Ramon-Maiques S, Marina A, Gil-Ortiz F, Fita I, Rubio V: Structure of acetylglutamate kinase, a key enzyme for arginine biosynthesis and a prototype for the amino acid kinase enzyme family, during catalysis. Structure. 2002 Mar;10(3):329-42.
2851495	Parsot C, Boyen A, Cohen GN, Glansdorff N: Nucleotide sequence of Escherichia coli argB and argC genes: comparison of N-acetylglutamate kinase and N-acetylglutamate-gamma-semialdehyde dehydrogenase with homologous and analogous enzymes. Gene. 1988 Sep 7;68(2):275-83.
8265357	Blattner FR, Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL: Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes. Nucleic Acids Res. 1993 Nov 25;21(23):5408-17.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2892

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
27160

# Drug_Target_1_Name:
Acetylglutamate kinase

# Drug_Target_1_Number_of_Residues:
258

# Drug_Target_1_PDB_ID:
1OHB

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00696	AA_kinase

# Drug_Target_1_Protein_Sequence:
>Acetylglutamate kinase
MMNPLIIKLGGVLLDSEEALERLFSALVNYRESHQRPLVIVHGGGCVVDELMKGLNLPVK
KKNGLRVTPADQIDIITGALAGTANKTLLAWAKKHQIAAVGLFLGDGDSVKVTQLDEELG
HVGLAQPGSPKLINSLLENGYLPVVSSIGVTDEGQLMNVNADQAATALAATLGADLILLS
DVSGILDGKGQRIAEMTAAKAEQLIEQGIITDGMIVKVNAALDAARTLGRPVDIASWRHA
EQLPALFNGMPMGTRILA

# Drug_Target_1_Reaction:
ATP + N-acetyl-L-glutamate = ADP + N-acetyl-L-glutamyl 5-phosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ATP + N-acetyl-L-glutamate = ADP + N-acetyl-L- glutamate 5-phosphate

# Drug_Target_1_SwissProt_ID:
P0A6C8

# Drug_Target_1_SwissProt_Name:
ARGB_ECOLI

# Drug_Target_1_Synonyms:
AGK
EC 2.7.2.8
N-acetyl-L- glutamate 5-phosphotransferase
NAG kinase

# Drug_Target_1_Theoretical_pI:
5.32

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AE004091

# Drug_Target_2_GenBank_ID_Protein:
9951641

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
argB

# Drug_Target_2_Gene_Sequence:
>906 bp
ATGACCCTGAGTCGCGATGACGCCGCCCAGGTTGCCAAGGTCCTTTCCGAGGCCCTGCCC
TACATCCGCCGCTTCGTCGGCAAGACGCTGGTGATCAAGTACGGCGGCAACGCCATGGAG
AGCGAGGAGCTGAAGGCCGGCTTCGCCCGCGACGTGGTGCTGATGAAAGCGGTCGGCATC
AACCCGGTGGTGGTGCATGGCGGCGGCCCGCAGATCGGAGACCTGCTCAAGCGCCTGTCG
ATCGAGAGCCACTTCATCGACGGCATGCGCGTCACCGACGCGGCGACCATGGACGTGGTG
GAGATGGTCCTCGGCGGCCAGGTGAACAAGGACATCGTCAACCTGATCAACCGCCACGGC
GGCAGCGCCATCGGCCTGACCGGCAAGGACGCCGAGCTGATCCGCGCGAAGAAGCTCACC
GTGACCCGCCAGACCCCGGAGATGACCAAGCCGGAGATCATCGACATCGGCCACGTGGGC
GAAGTCACCGGGGTCAACGTCGGGCTGCTGAACATGCTGGTCAAGGGCGACTTCATTCCG
GTGATCGCGCCGATCGGCGTGGGCAGCAACGGCGAGTCCTACAACATCAATGCCGACCTG
GTGGCCGGCAAGGTGGCGGAAGCGCTGAAGGCCGAGAAACTGATGCTGCTGACCAACATC
GCCGGCCTGATGGACAAGCAGGGCCAGGTGCTGACCGGGCTGTCCACCGAACAGGTCAAC
GAGCTGATCGCCGACGGCACCATCTACGGCGGCATGCTGCCGAAGATCCGCTGCGCCCTG
GAAGCGGTGCAGGGCGGCGTGACCAGCGCGCACATCATCGATGGCCGGGTACCGAATGCC
GTGCTGCTGGAAATCTTCACCGACAGCGGCGTCGGCACCCTGATCAGCAACCGCAAGCGT
CACTGA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
12037312	Fernandez-Murga ML, Ramon-Maiques S, Gil-Ortiz F, Fita I, Rubio V: Towards structural understanding of feedback control of arginine biosynthesis: cloning and expression of the gene for the arginine-inhibited N-acetyl-L-glutamate kinase from Pseudomonas aeruginosa, purification and crystallization of the recombinant enzyme and preliminary X-ray studies. Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6 Pt 2):1045-7. Epub 2002 May 29.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3550

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
31850

# Drug_Target_2_Name:
Acetylglutamate kinase

# Drug_Target_2_Number_of_Residues:
301

# Drug_Target_2_PDB_ID:
1UVD

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00696	AA_kinase

# Drug_Target_2_Protein_Sequence:
>Acetylglutamate kinase
MTLSRDDAAQVAKVLSEALPYIRRFVGKTLVIKYGGNAMESEELKAGFARDVVLMKAVGI
NPVVVHGGGPQIGDLLKRLSIESHFIDGMRVTDAATMDVVEMVLGGQVNKDIVNLINRHG
GSAIGLTGKDAELIRAKKLTVTRQTPEMTKPEIIDIGHVGEVTGVNVGLLNMLVKGDFIP
VIAPIGVGSNGESYNINADLVAGKVAEALKAEKLMLLTNIAGLMDKQGQVLTGLSTEQVN
ELIADGTIYGGMLPKIRCALEAVQGGVTSAHIIDGRVPNAVLLEIFTDSGVGTLISNRKR
H

# Drug_Target_2_Reaction:
ATP + N-acetyl-L-glutamate = ADP + N-acetyl-L-glutamyl 5-phosphate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
ATP + N-acetyl-L-glutamate = ADP + N-acetyl-L- glutamate 5-phosphate

# Drug_Target_2_SwissProt_ID:
Q9HTN2

# Drug_Target_2_SwissProt_Name:
ARGB_PSEAE

# Drug_Target_2_Synonyms:
AGK
EC 2.7.2.8
N-acetyl-L- glutamate 5-phosphotransferase
NAG kinase

# Drug_Target_2_Theoretical_pI:
6.81

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04075
